Does Ginkgo help blood sugar? (Grade C evidence)
For blood sugar, Ginkgo sits at Grade C — a hint of benefit in limited trials, especially in adults with metabolic risk factors, low certainty, at doses varies across trials.
Exact question reviewed
- Population
- adults with metabolic risk factors
- Intervention
- Ginkgo · varies across trials
- Comparator
- not reported
- Outcome
- blood sugar
- Time horizon
- not reported
Bottom line. For blood sugar, Ginkgo sits at Grade C — a hint of benefit in limited trials, especially in adults with metabolic risk factors, low certainty, at doses varies across trials. [1 RCT]
- Direction
- benefit
- Magnitude
- Meta-analysis: Ginkgo biloba extract significantly reduced fasting blood glucose and improved insulin resistance (HOMA-IR) versus control, plus reduced BMI and waist circumference, but did NOT significantly change HbA1c or fasting insulin levels — a partial biomarker signal, not comprehensive glycemic control.
- Grade
- C
- Certainty
- low
- Clinical meaning
- small but potentially useful
- Who it applies to
- adults with metabolic risk factors
- Dose / form studied
- varies across trials
- Safety
- serious_with_warfarin; moderate_with_ssri
- The one limitation
- Claim-specific limitation details are not available in this public record.
Reviewed · Evidence last changed · Claim clm_ec_b9-ginkgo-blood-sugar v0
⚠ Safety in context
- seriouswith Warfarin: Ginkgo has antiplatelet activity; with warfarin it may increase bleeding risk. full interaction →
- moderatewith SSRI: Possible additive bleeding/serotonergic effects with SSRIs. full interaction →
Grade C / low: hints of benefit in small trials; a well-run RCT could easily push this to B or to null.
Who it works for
Best-studied in adults with metabolic risk factors. Recorded studied dose: varies across trials.
Evidence
| Study | Design | Role | Cite |
|---|---|---|---|
| Effects of Ginkgo biloba extract on glycemic control, inflammatory markers, lipid profile, anthropometric indices, and safety parameters in patients with metabolic syndrome and type 2 diabetes: a meta-analysis. | peer-reviewed | supports | PMID:42157337 |
Why this grade
Reasoning trace
The current record stores Grade C at low certainty and links 1 publishable source. A claim-specific domain-by-domain grading rationale is not available in this public record, so no reason for upgrading or downgrading is inferred here.
Audit and version
- Claim ID
- ec_b9-ginkgo-blood-sugar
- Claim version
- not reported
- Governance
- legacy, not verified
- Last evidence search
- not reported
- Last editorial review
- 2026-07-16T16:40:51.601Z
Dose & form
Studied intake: varies across trials.
How it stacks up for blood sugar
- Ginkgo vs Berberine for blood sugar — Berberine Grade B
- Ginkgo vs Magnesium for blood sugar — Magnesium Grade C
- Ginkgo vs Myo-Inositol for blood sugar — Myo-Inositol Grade B
- Ginkgo vs Ashwagandha for blood sugar — Ashwagandha Grade C
- Ginkgo vs Omega-3 for blood sugar — Omega-3 Grade B
- Ginkgo vs Creatine for blood sugar — Creatine Grade C
- All interventions graded for blood sugar →
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+) — next review by . Methodology v1.
Re-review cadence: every 6 months (Grade C+) · next scheduled by · methodology v1.
Frequently asked
How long does Ginkgo take to work for blood sugar?
Trials of Ginkgo for blood sugar typically report effects within 2–4 weeks, though individual response varies. Studies rarely find benefit inside 1 week for chronic outcomes.
What dose was used in studies of Ginkgo for blood sugar?
Studied doses for Ginkgo in blood sugar trials cluster around varies across trials. See the dose block for the specific range and how it varies by form.
Does Ginkgo work for blood sugar if I'm not deficient?
The effect concentrates in adults with metabolic risk factors. If your baseline is normal, expect a smaller effect than the trial averages.
Ginkgo or the next-best alternative for blood sugar?
See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.
Related
What this is — and is not
- Evidence description
- Meta-analysis: Ginkgo biloba extract significantly reduced fasting blood glucose and improved insulin resistance (HOMA-IR) versus control, plus reduced BMI and waist circumference, but did NOT significantly change HbA1c or fasting insulin levels — a partial biomarker signal, not comprehensive glycemic control.
- Substrate's interpretation
- The current reviewed record assigns Grade C at low certainty. A domain-by-domain rationale is shown only when recorded.
- Discuss with a clinician
- If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
- Individualized medical advice
- Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.
Cite this page
Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.
Plain-text citation
Substrate. Does Ginkgo help blood sugar? (Grade C). https://evidencebased.info/interventions/ginkgo/blood-sugar. Updated 2026-07-16.
BibTeX
@misc{substrate_ionsginkgobloodsugar,
author = {Substrate editorial},
title = {Does Ginkgo help blood sugar?},
year = {2026},
url = {https://evidencebased.info/interventions/ginkgo/blood-sugar},
note = {Grade C, evidencebased.info}
}Found something wrong on this page? Report an error →